Catalyst Wire Dossier Catalyst Wire Dossier

CB-03-01 cream

· Intrepid Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CB-03-01 cream, covering 2020-10-19 to 2020-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) [Phase 3]

See pricing